EMEA-000365-PIP01-08-M10

Key facts

Invented name
Tamiflu
Active substance
Oseltamivir (phosphate)
Therapeutic area
Infectious diseases
Decision number
P/0251/2018
PIP number
EMEA-000365-PIP01-08-M10
Pharmaceutical form(s)
  • Capsule, hard
  • Powder for oral suspension
Condition(s) / indication(s)
Treatment and prevention of influenza
Route(s) of administration
Oral use
Contact for public enquiries
Roche Registration GmbH

E-mail: global.paediatrics@roche.com
Tel. +41 6168 79411

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating